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Cornea
Nerves and Neovessels Inhibit Each Other in the Cornea
Giulio Ferrari,1–3 Amir R. Hajrasouliha,1,3 Zahra Sadrai,1 Hiroki Ueno,1 Sunil K. Chauhan,1
and Reza Dana1
PURPOSE. To evaluate the regulatory cross-talk of the vascular
and neural networks in the cornea.
METHODS. b-FGF micropellets (80 ng) were implanted in the
temporal side of the cornea of healthy C57Bl/6 mice. On
day 7, blood vessels (hemangiogenesis) and nerves were
observed by immunofluorescence staining of corneal flat
mounts. The next group of mice underwent either
trigeminal stereotactic electrolysis (TSE), or sham operation,
to ablate the ophthalmic branch of the trigeminal nerve.
Blood vessel growth was detected by immunohistochemis-
try for PECAM-1 (CD31) following surgery. In another set of
mice following TSE or sham operation, corneas were
harvested for ELISA (VEGFR3 and pigment epithelium-
derived factor [PEDF]) and for quantitative RT-PCR
(VEGFR3, PEDF, and CD45). PEDF, VEGFR3, beta-3 tubulin,
CD45, CD11b, and F4/80 expression in the cornea were
evaluated using immunostaining.
RESULTS. No nerves were detected in the areas subject to
corneal neovascularization, whereas they persisted in the areas
that were neovessel-free. Conversely, 7 days after denervation,
significant angiogenesis was detected in the cornea, and this
was associated with a significant decrease in VEGFR3 (57.5%
reduction, P ¼ 0.001) and PEDF protein expression (64%
reduction, P < 0.001). Immunostaining also showed reduced
expression of VEGFR3 in the corneal epithelial layer. Finally, an
inflammatory cell infiltrate, including macrophages, was
observed.
CONCLUSION. Our data suggest that sensory nerves and neo-
vessels inhibit each other in the cornea. When vessel growth is
stimulated, nerves disappear and, conversely, denervation
induces angiogenesis. This phenomenon, here described in
the eye, may have far-reaching implications in understanding
angiogenesis. (Invest Ophthalmol Vis Sci. 2013;54:813–820)
DOI:10.1167/iovs.11-8379
There are considerable similarities between the develop-ment of the vascular and nervous systems. At the
anatomical level, the nerves and the vascular network course
parallel to one another, often with a similar branching pattern.
At the cellular level, both systems require precise control over
their guidance and growth,1–6 which is regulated by several
common molecules with attractive and repulsive properties,
including the semaphorins, slits, netrins, and their recep-
tors.7–10 Despite these similarities, the interactions of these
two networks are not well understood, in particular in the
central nervous system, where an intricate ‘‘barrier’’ appears to
modulate the neuronal–blood vessel interaction. This barrier,
although well known as the blood-brain-barrier, is not limited
to brain and includes blood-cerebral, blood–spinal cord, and
blood-retinal barriers. Interestingly, angiogenesis has been
shown to contribute to epileptogenesis in experimental and
human epilepsy.11–14 These facts raise the question regarding
the functional interactions of these two networks.
The normal cornea is the most densely innervated tissue in
the human body,15 yet devoid of blood vessels. However, many
corneal pathological conditions, such as inflammatory disor-
ders, alkali burns, corneal graft rejection, infectious keratitis,
and limbal stem cell deficiency, would disrupt the avascular
microenvironment and lead to corneal angiogenesis.16 Thus,
there is a delicate balance between angiogenic (e.g., angioge-
nin,17 FGF,18 hepatocyte growth factor,19 VEGFs,20 and so
forth) and antiangiogenic factors (e.g., angiostatin,21 endo-
statin,22 VEGF receptors,23 pigment epithelium-derived factor
[PEDF],24 thrombospondin 1 and 225) in the cornea. Because
corneal avascularity is sharply demarcated at the limbus (the
border between the vascularized conjunctiva and avascular
cornea) the ‘‘limbal barrier’’ has been identified as a critical
feature of corneal avascularity.22–25 In fact, the concept of a
limbal barrier is corroborated by the increase in corneal
neovascularization seen in pathological limbal stem cell
deficiency and experimental limbal damage,26 where conjunc-
tival (vascular) tissue grows into the cornea.
Similar to the vascular system, which is prone to
perturbations of the ocular surface, corneal nerves are also
prone to injury in many pathological conditions, such as ocular
infection, topical anesthetic abuse, surgery, diabetes, stroke,
and dry eye syndrome.27–29 While pathological corneal
vascularization and nerve loss are correlated through inflam-
mation, the direct relationship between nerve loss and corneal
vascularization has not been studied per se. Here we aimed to
examine whether the loss of the nerve in the cornea could
result in disruption of the corneal vascular privilege. The
avascularity of the cornea, despite its extensive innervation,
provides a unique in vivo milieu to interrogate the interaction
of neuronal and vascular networks in different settings.
In this article, we demonstrate for the first time that corneal
nerves and vessels inhibit each other in a tight spatial and
temporal fashion. We show that this effect is, in part, mediated
by alterations in angiostatic molecules, PEDF, and VEGFR3,
constitutively expressed by the normal cornea.
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METHODS
Animals
Male 6- to 8-week-old C57Bl/6 mice (Taconic Farms, Germantown, NY)
were used in all experiments. Animals were anesthetized by
intraperitoneal injection of ketamine (120 mg/kg) and xylazine (20
mg/kg) before any surgery and were treated in accordance with the
Association for Research in Vision and Ophthalmology Statement for
the Use of Animals in Ophthalmic and Vision Research and approved
by the Schepens Eye Research Institute Animal Care and Use
Committee.
Pellet Implantation
b-FGF micropellets (80 ng/pellet) were prepared as described
previously.30 Briefly, the pellets were implanted through half-thickness
linear incisions at the center of cornea using a disposable 308
microknife (F.S.T., Foster City, CA). Lamellar pocket incisions were
then made parallel to the corneal plane using a Von Graefe knife (F.S.T.)
and advanced to the temporal limbus at lateral canthal area. The pellets
were positioned into the pocket 1.0 mm apart from the limbal vascular
arcade, and tetracycline ophthalmic ointment was applied to the eye
after pellet implantation.
Trigeminal Nerve Ablation
Trigeminal nerve ablation was performed as described previously.31
This technique leads to extensive disruption and vacuolization of the
corneal nerves, followed by the development of neurotrophic
keratitis.31 Briefly, animals were anesthetized and a stereotactic
frame was fixed to the animal head. A median incision was made on
the skull. The bregma (the point of conjunction of coronal and
sagittal sutures) was identified and chosen as a point of reference.
The skull was opened with a dental drill, a conductive unimodal
electrode (FHC, Bowdoin, ME) was lowered (depth: 0.63 cm) at
three different locations (relative to bregma: 0.15 cm anterior and
0.08 cm lateral; 0.09 anterior and 0.10 lateral; 0.09 anterior and 0.12
lateral) on the ophthalmic trigeminal nerve, and a 2-mA current was
passed for 15 seconds. The electrode was removed and the skin
sutured. A lateral tarsorrhaphy was performed to reduce the risk of
infection. Finally, antibiotic ointment (bacitracin-neomycin-polymi-
cin) was applied to the sutural area and the treated eye.
Buprenorphine (0.1 mg/kg body weight every 8–12 hours for 72
hours) was injected subcutaneously. Corneal sensitivity using a
cotton filament was recorded pre- and postoperatively. The eyelids
were closed with a suture tarsorrhaphy after the procedure and
opened 7 days later.
FIGURE 1. Growth of neovessels is associated with corneal nerve
degeneration observed in both the epithelium and stroma. ‘‘P’’ ¼
intracorneal pellet. Note that vessels are growing toward the pellet,
whereas no vessels are visible opposite to the pellet. Beta-3 tubulin
(red staining) reveals corneal nerves in the epithelium and stroma on
the opposite side of the pellet (arrows). In contrast, adjacent to the
pellet no nerves are detected, whereas PECAM staining (green)
confirms the presence of neovessels (indicated by arrowheads).
FIGURE 2. Corneal nerves and vessels inhibit each other in the cornea.
(A) Corneal nerves are undetectable 48 hours following trigeminal
stereotactic electrolysis (beta-3 tubulin staining), right: denervated eye;
left: normal eye. (B) Neovascularization occurs 7 days after denervation
in the cornea (right), in contrast to the normal cornea (left). (C)
Immunostaining for PECAM showing growth of neovessels following
denervation (right).
814 Ferrari et al. IOVS, January 2013, Vol. 54, No. 1
Immunohistochemistry and Morphometry
After taking photographs under the slit lamp, five mice per group were
killed 7 days after b-FGF micropellet implantation or trigeminal nerve
ablation, and freshly enucleated eyes were prepared into corneal flat
mounts. The following primary antibodies were used for immunohis-
tochemical staining: FITC-conjugated rat anti-mouse CD45 (pan-
leukocyte marker; BD Biosciences; San Diego, CA), FITC-conjugated
rat anti-mouse CD11b (BD Biosciences), FITC-conjugated anti-mouse
F4/80 (eBioscience, San Diego, CA), polyclonal rabbit anti-mouse FLT-4,
M-20 (Santa Cruz Biotechnology, Santa Cruz, CA), and goat polyclonal
IgG anti-PEDF (Santa Cruz Biotechnology). Corneal neovessels and
nerves were immunostained with FITC-conjugated CD31/PECAM-1 (rat
anti- mouse antibody; Santa Cruz Biotechnology) and with anti-3
tubulin primary antibody (rabbit anti–beta-3 tubulin polyclonal
antibody, Chemicon, Temecula, CA). For whole-mount corneal
staining, freshly excised corneas were washed in PBS and fixed in
acetone for 15 minutes. Nonspecific staining was blocked with anti-
FcR CD16/CD32 antibody (BD Biosciences). Specimens were immu-
nostained with primary for 2 hours, washed with PBS, incubated with
secondary antibody, and mounted with Vector Shield mounting
medium (Vector Laboratories, Burlingame, CA). Corneas were analyzed
using confocal microscopy (Leica TCS 4D; Leica, Heidelberg, Germany)
at 340 magnification. At least three to five different corneas were
examined per each double-staining experiment; representative data are
presented below (Fig. 1).
Quantitative RT-PCR and ELISA
RNA was isolated from corneas by RNeasy Micro Kit (Qiagen, Valencia,
CA) and reverse transcribed (Superscript III Kit; Invitrogen Life
Technologies, Carlsbad, CA). Quantitative RT-PCR (qRT-PCR) was
performed (TaqMan Universal PCR MasterMix; Applied Biosystems,
Foster City, CA), and primers (Applied Biosystems) were preformulated
for VEGFR-3 (assay ID: Mm00433337_ml), PEDF (assay ID: Mm
00441270_m1) and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (assay ID: Mm99999915_gl), CD45 (assay ID:
Mm00448490_m1). Results were derived from the comparative
threshold cycle method and normalized by GAPDH as an internal
control. Values obtained from normal corneas were then used to
calculate relative mRNA expression for experimental corneas.
Levels of PEDF and ELISA in denervated and control corneas were
analyzed using commercially available kits (MyBiosource, Inc., San
Diego, CA) as per the manufacturer’s instructions. Corneas were
homogenized and diluted with RIPA buffer and Protease inhibition
cocktail (Sigma, St. Louis, MO).
Statistical Analysis
Error bars displayed in the figures were calculated from the SEM
(6SEM). Student’s t-test was performed to compare the level of mRNA
in qRT-PCR. P less than 0.05 was considered statistically significant.
Results are presented as the mean 6 SEM.
FIGURE 3. Reduction of normally present angiostatic molecules following denervation of the cornea (A, mRNA expression; B, protein expression).
PEDF and VEGFR3 are both significantly reduced 7 days after TSE. Bars indicate standard error.
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RESULTS
Corneal Nerves Were Undetectable in the Area with
Neovessel Formation
Corneas implanted with b-FGF pellets developed neovascular-
ization toward the pellet site, as confirmed by slit lamp
examination and immunostaining. Neovessels were evident
histologically as a densely branched network (Fig. 1, right
bottom panel). In the area where neovessels grew, both
superficial intraepithelial and deeper stromal corneal nerves
were entirely absent (right panels, Fig. 1). In contrast, in
sectors of the cornea spared by neovascularization, abundant
nerves could be detected, both in the epithelium and in the
stroma, unchanged compared with the normal baseline (left
panels, Fig. 1). Epithelial nerves appeared as a delicate and
interconnected network, whereas stromal nerves were consti-
tuted by thicker trunks. These data suggest that corneal nerves
are damaged and disappear following development of corneal
neovascularization.
Corneal Vessels in the Denervation Model
As evaluated by immunohistochemistry, nerves could not be
detected in the trigeminal stereotactic electrolysis (TSE)-
treated (denervated) cornea, 7 days after TSE, in contrast to
the normal contralateral eye and the sham-operated eye (Fig.
2A). Interestingly, 7 days following TSE-induced corneal
FIGURE 4. Differential expression of PEDF, beta-3 tubulin, and CD45 in the corneal epithelium (A), stroma (B), and corneal nerves (C). (A) The
normal corneal epithelium diffusely expresses PEDF (red). (B) Epithelial bone-marrow derived CD45þ cells (in green, arrows) do not double stain
for PEDF (red). (C) Epithelial nerves, stained by anti-beta-3 tubulin (green), are not stained by anti-PEDF antibody. Stromal nerves co-stain for anti-
PEDF antibody and anti–beta-3 tubulin in some areas (a, inset I), but not others (b).
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denervation, neovessels were observed in the cornea by means
of biomicroscopy (Fig. 2B). This was further confirmed by
PECAM immunostaining (Fig. 2C), suggesting that corneal
denervation is followed rapidly by corneal neovascularization.
PEDF and VEGFR3 mRNA and Protein Expression
Levels
The expression of the angiostatic factors PEDF and VEGFR3,
measured with real-time PCR, were both significantly reduced
in the denervated compared with the normal corneas. PEDF
expression was significantly reduced (56% reduction, P ¼
0.012). VEGFR3 expression was also significantly reduced after
denervation (48% reduction, P¼0.007) (Fig. 3A). Protein levels
of PEDF and VEGFR3 were also reduced after denervation
(64%; P < 0.001 and 57.5%; P ¼ 0.001) respectively (Fig. 3B).
These data suggest that two major angiostatic mechanisms
that are physiologically responsible for corneal avascularity are
subverted following corneal denervation. The expression of
CD45 receptor, a marker for inflammatory cell infiltration, was
increased following corneal denervation when compared with
normal controls (220 6 110 vs. 111 6 17; P < 0.05). Finally,
PEDF immunostaining of corneal whole-mounts was robust in
the corneal epithelium, sporadic in the stromal nerves, and
absent in the epithelial nerves or CD45þ immune cells (Fig. 4),
suggesting that epithelial cells and some of the stromal nerves
are a source of PEDF.
Immunostaining for VEGFR3, CD45, CD11b, and
F4/80
VEGFR3 expression was reduced in the epithelium following
denervation (Figs. 5A, 5B; in X-Y plane). This was further
confirmed by Z-plane stacking of all the scanned layers of
epithelium, which revealed reduced signal intensity after TSE
(Fig. 5C).
Sporadic CD11bþ and F4/80þ cells were detected in normal
corneas. Following denervation both markers appeared evi-
dently increased in the corneal stroma (Fig. 6).
DISCUSSION
The normal cornea is densely innervated (several hundred-fold
higher than skin15), and completely avascular. The underlying
reasons for corneal avascularity have been the subject of many
studies and some controversy for decades. It has been shown
that angiostatic molecules are constitutively expressed by the
cornea, in particular the epithelium,23,32,33 and that limbal
stem cells, together with the particular collagen ultrastructure
of the cornea, may represent barriers to the ingrowth of
neovessels.34,35 However, it has not been clear whether the
dense innervation of the cornea is involved in the maintenance
of avascularity. This question has been confounded by the fact
that peripheral nerves are known to secrete neuropeptides,
some of which promote angiogenesis (such as nerve growth
factor36), while others are angiostatic (i.e., PEDF37).
Clinical observation provides some clues, in the form of
corneal ‘‘neurotrophic keratopathy,’’ which is a disease
characterized by disruption of corneal nerves. It is a frequent
clinical observation that patients affected with this disease are
more prone to developing corneal neovascularization. More-
over, patients affected by aniridia, a clinical condition caused
by absence of the iris and other congenital ocular defects
including reduced corneal nerve density,38,39 frequently
present with corneal neovascularization.40
To test the hypothesis that vessels and nerves inhibit each
other in the cornea, we used two different animal models. The
first involved the use of proangiogenic pellets implanted in the
cornea with the purpose of inducing sectoral corneal
neovascularization so as to compare the effect of corneal
neovascularization on distinct (vascularized and avascular)
sections of the cornea. Interestingly, we found that both the
superficial epithelial and deep stromal corneal nerves disap-
peared entirely in the sectors involved by neovessels, while
persisting in the nonvascularized areas. b-FGF has been
reported to have some neuroprotective effects under certain
conditions of ischemia,41 despite our observation that high
concentrations of b-FGF placed in the corneal micropocket led
to complete corneal nerve depletion. One possibility to
explain this is that infiltration of inflammatory cells induced
FIGURE 5. Confocal micrographs in X-Y plane showing that VEGFR3 expression is present in the normal corneal epithelium (A), and reduced
following denervation (B). Z-plane stacking of all epithelial images in X-Y plane shows reduced expression in the denervated corneal epithelium (C).
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by angiogenesis (in response to high local b-FGF levels)
through the highly permeable ‘‘leaky’’ neovessel wall could
directly induce local nerve loss. The relationship between
inflammation and neural survival/death is complex, and is
unlikely to be direct or linear. For example, interleukin-1 (IL-1)
and b-FGF are increased significantly following tissue damage
in the central nervous system,42,43 and although b-FGF has
been implicated in neuroprotection in certain ischemia
models, IL-1 has been shown to have detrimental effects in
brain hypoxia.44 Another level of complexity is that different
local concentrations of b-FGF and other cytokines that define
the inflammatory tissue microenvironment may have very
different effects on inducing nerve regeneration (versus death).
In the aggregate, however, given the high density of nerves
concurrent with the cornea’s absolute avascularity in the
normal state, and the vascularized cornea’s association with
near-total absence of nerves, suggests strongly that corneal
innervation is a critical facet of its avascularity.
To formally test whether the ablation of corneal nerves
could stimulate neovessel growth, we used a recently
developed model of TSE, which we have demonstrated can
induce both epithelial and stromal corneal nerve degenera-
tion.15 As reduced blinking could lead to corneal infection and
inflammation, potentially confounding factors, we performed a
tarsorrhaphy (lid-closure procedure) and opened the eyes 7
days later. Just as we had found angiogenesis to lead to nerve
loss, we found that denervation was associated with significant
growth of neovessels in the cornea. Previous work has shown
that removal of sympathetic nerves is associated with choroidal
and retinal neovascularization.45 Similarly, ablation of periph-
eral dopaminergic nerves has been shown to stimulate
angiogenesis in malignant tumors.46 However, to the best of
our knowledge, there has been no report describing the
influence of sensory innervation on ocular, including corneal,
neovascularization thus far.
To better understand the mechanisms by which this
regulation occurs, we hypothesized that the corneal epitheli-
um, which is known for its angiostatic properties, such as
constitutive expression of epithelial VEGFR3,3 may be altered
after denervation. Ectopic expression of VEGFR3 by the
corneal epithelium acts as a ‘‘sink’’ for VEGF ligands and
hence contributes to preserve corneal avascularity.23 In this
FIGURE 6. Characterization of inflammatory cell infiltrate following corneal denervation. Both CD11b (A, green) and F4/80 (B, green) expression is
significantly increased in denervated corneas.
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regard, we found that VEGFR3 protein expression was reduced
by more than half following denervation. We also observed an
evident reduction in the VEGFR3 with immunostaining. This
supports the hypothesis that denervation induces a proangio-
genic shift in the cornea. In addition, because inflammatory
cells serve as key sources for proangiogenic cytokines,
including VEGF, and thus serve as key stimulators of
neovascularization,47,48 we measured the expression of CD45
(a receptor expressed broadly by bone marrow–derived
leukocytes), and found it significantly increased following
denervation. This is consistent with previous observations of
CD45þ cell infiltration in the denervated corneas31 and was
further confirmed by the increase of CD11bþ and F4/80þ cells
following denervation. F4/80 is a marker for macrophages,
which are known to be associated with corneal neovascular-
ization.22
PEDF, a potent antiangiogenic molecule, has been shown to
immunolocalize to the corneal epithelium and endothelium.49
It is expressed in a broad range of human fetal and adult
tissues. Consistent with its angiostatic properties, PEDF-
blocking antibodies implanted in the cornea facilitate corneal
neovascularization.37 PEDF is the only molecule described so
far in the cornea that presents both neurotrophic and
angiostatic properties; hence, it is the ideal candidate for
being involved in the ‘‘cross-talk’’ between corneal nerves and
vessels. Accordingly, we hypothesized that denervation would
cause a reduction in PEDF expression consistent with both
nerve loss and resultant corneal angiogenesis. In accord with
this hypothesis, we noted that after denervation, PEDF protein
expression was significantly reduced (more than half),
suggesting that suppressed PEDF expression could disinhibit
angiogenesis and be (at least in part) responsible for the
corneal neovascularization. To better delineate the cellular
sources of PEDF in the cornea, we conducted experiments
immunostaining for PEDF, CD45, and beta-3 tubulin. Our
results demonstrate that corneal epithelium is the principal
source of PEDF, supporting its angiostatic role for corneal
stromal nerves through its constitutive PEDF expression.
Stromal nerves were found to express PEDF sporadically. In
contrast to the epithelium that contributes to corneal
avascularity (its so-called ‘‘angiogenic privilege’’), ample data
suggest that CD45þ leukocytes that are mobilized in corneal
inflammatory disorders, including the denervated cornea,31
stimulate angiogenesis through secretion of a broad array of
proangiogenic cytokines, including VEGF-A.48
In summary, in this study, we provide direct evidence that
corneal nerves and vessels inhibit one another, a cross-talk that
our data suggest is mediated, at least in part, by the reduction
of angiostatic molecules constitutively expressed in physiolog-
ic conditions by the cornea, including epithelial-derived PEDF
and epithelial VEGFR3. It is conceivable that the inhibitory
cross-regulation between the sensory nerves and angiogenesis,
as described herein, may have implications beyond the cornea,
such as inflammatory, and possibly neoplastic angiogenesis, in
different tissues.
References
1. Tessier-Lavigne M, Goodman CS. The molecular biology of
axon guidance. Science. 1996;274:1123–1133.
2. Dickson BJ. Molecular mechanisms of axon guidance. Science.
2002;298:1959–1964.
3. Huber AB, Kolodkin AL, Ginty DD, Cloutier, JF. Signaling at the
growth cone: ligand-receptor complexes and the control of
axon growth and guidance. Annu Rev Neurosci. 2003;26:509–
563.
4. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A,
Abramsson A, et al. VEGF guides angiogenic sprouting utilizing
endothelial tip cell filopodia. J Cell Biol. 2003;161:1163–1177.
5. Carmeliet P, Smet FD, Loges S, Mazzone M. Branching
morphogenesis and antiangiogenesis candidates: tip cells lead
the way. Na. Rev Clin Oncol. 2009;6:315–326.
6. Dorrell MI, Aguilar E, Friedlander M. Retinal vascular
development is mediated by endothelial filopodia, a preexist-
ing astrocytic template and specific R-cadherin adhesion.
Invest Ophthalmol Vis Sci. 2002;43:3500–3510.
7. Suchting S, Bicknell R, Eichmann A. Neuronal clues to vascular
guidance. Exp Cell Res. 2006;312:668–675.
8. Larrive´e B, Freitas C, Suchting S, Brunet I, Eichmann A.
Guidance of vascular development: lessons from the nervous
system. Circ Res. 2009;104:428–441.
9. Jones CA, Li DY. Common cues regulate neural and vascular
patterning. Curr Opin Genet Dev. 2007;17:332–336.
10. Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood-brain
barrier pathology in Alzheimer’s and Parkinson’s disease:
implications for drug therapy. Cell Transplant. 2007;16:285–
299.
11. Torres-Va´zquez J, Gitler AD, Fraser SD, et al. Semaphorin-
plexin signaling guides patterning of the developing vascula-
ture. Dev Cell. 2004;7:117–123.
12. Friedman A, Kaufer D, Heinemann U. Blood-brain barrier
breakdown-inducing astrocytic transformation: novel targets
for the prevention of epilepsy. Epilepsy Res. 2009;85:142–149.
13. Ndode-Ekane XE, Hayward N, Gro¨hn O, Pitka¨nen A. Vascular
changes in epilepsy: functional consequences and association
with network plasticity in pilocarpine-induced experimental
epilepsy. Neuroscience. 2010;166:312–332.
14. Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A,
Shelef I. Blood-brain barrier breakdown following traumatic
brain injury: a possible role in posttraumatic epilepsy.
Cardiovasc Psychiatry Neurol. 2011;2011:765923.
15. Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis.
Eye (Lond). 2003;17:989–995.
16. Sellami D, Abid S, Bouaouaja G, Ben Amor S, Kammoun B,
Masmoudi M, et al. Epidemiology and risk factors for corneal
graft rejection. Transplant Proc. 2007;38:2609–2611.
17. Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness
of cultured endothelial cells by stimulation of cell-associated
proteolytic activities. Proc Natl Acad Sci U S A. 1994;91:
12096–12100.
18. Sunderko¨tter C, Roth J, Sorg C. Immunohistochemical
detection of bFGF and TNF-alpha in the course of inflamma-
tory angiogenesis in the mouse cornea. Am J Pathol. 1990;
137:511–515.
19. Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, et al.
Hepatocyte growth factor enhances vascular endothelial
growth factor-induced angiogenesis in vitro and in vivo. Am
J Pathol. 2001;158:1111–1120.
20. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP.
Requirement for vascular endothelial growth factor in wound-
and inflammation-related corneal neovascularization. Invest
Ophthalmol Vis Sci. 1998;39:18–22.
21. Ambati BK, Joussen AM, Ambati J, Moromizato Y, Guha C,
Javaherian K, et al. Angiostatin inhibits and regresses corneal
neovascularization. Arch Ophthalmol. 2002;120:1063–1068.
22. Azar DT. Corneal angiogenic privilege: angiogenic and
antiangiogenic factors in corneal avascularity, vasculogenesis,
and wound healing (an American Ophthalmological Society
thesis). Trans Am Ophthalmol Soc. 2006;104:264–302.
23. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S,
et al. Nonvascular VEGF receptor 3 expression by corneal
epithelium maintains avascularity and vision. Proc Natl Acad
Sci U S A. 2006;103:11405–11410.
IOVS, January 2013, Vol. 54, No. 1 Corneal Nerves and Neovessels 819
24. Abdiu O, Van Setten G. Antiangiogenic activity in tears:
presence of pigment-epithelium-derived factor. New insights
and preliminary results. Ophthalmic Res. 2008;40:16–18.
25. Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, et
al. Roles of thrombospondin-1 and 2 in regulating corneal
and iris angiogenesis. Invest Ophthalmol Vis Sci. 2004;45:
1117–1124.
26. Ashton N. Cornea vascularization. In: Duke-Elder S, Perkins ES,
eds. The Transparency of the Cornea. A Symposium. Oxford,
UK: Blackwell Scientific Publications; 1960:131–147.
27. Lim P, Fuchsluger TA, Jurkunas UV. Limbal stem cell deficiency
and corneal neovascularization. Semin Ophthalmol. 2009;24:
139–148.
28. Epstein DL, Paton D. Keratitis from misuse of corneal
anesthetics. N Engl J Med. 1968;279:396–399.
29. Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-
Sanchez J. An in vivo confocal masked study on corneal
epithelium and subbasal nerves in patients with dry eye.
Invest Ophthal Vis Sci. 2004;45:3030–3035.
30. Chung ES, Saban DR, Chauhan SK, Dana R. Regulation of
blood vessel versus lymphatic vessel growth in the cornea.
Invest Ophthalmol Vis Sci. 2009;50:1613–1618.
31. Ferrari G, Chauhan SK, Ueno H, Nallasamy N, Gandolfi S,
Borges L, et al. A novel mouse model for neurotrophic
keratopathy: trigeminal nerve stereotactic electrolysis through
the brain. Invest Ophthalmol Vis Sci. 2011;52:2532–2539.
32. Philipp W, Speicher L, Humpel C. Expression of vascular
endothelial growth factor and its receptors in inflamed and
vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;
41:2514–2522.
33. Singh N, Amin S, Richter E, Rashid S, Scoglietti V, Jani PD, et al.
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in
vitro and corneal neovascularization in vivo. Invest Ophthal-
mol Vis Sci. 2005;46:1647–1652.
34. Huang AJ, Tseng SC. Corneal epithelial wound healing in the
absence of limbal epithelium. Invest Ophthalmol Vis Sci.
1991;32:96–105.
35. Tseng SC. Concept and application of limbal stem cells. Eye
(Lond). 1989;3:141–157.
36. Lazarovici P, Gazit A, Staniszewska I, Marcinkiewicz C, Lelkes
PI. Nerve growth factor (NGF) promotes angiogenesis in the
quail chorioallantoic membrane. Endothelium. 2006;13:51–
59.
37. Meyer C, Notari L, Becerra SP. Mapping the type I collagen-
binding site on pigment epithelium-derived factor. Implica-
tions for its antiangiogenic activity. J Biol Chem. 2002;277:
45400–45407.
38. Ede´n U, Riise R, Tornqvist K. Corneal involvement in
congenital aniridia. Cornea. 2010;29:1096–1102.
39. Leiper LJ, Ou J, Walczysko P. Control of patterns of corneal
innervation by Pax6. Invest Ophthalmol Vis Sci. 2009;50:
1122–1128.
40. Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S.
Ocular surface abnormalities in aniridia. Am J Ophthalmol.
1995;120:368–375.
41. Alzheimer C, Werner S. Fibroblast growth factors and
neuroprotection. Adv Exp Med Biol. 2002;513:335–351.
42. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT.
Post-ischemic brain damage: pathophysiology and role of
inflammatory mediators. FEBS J. 2009;276:13–26.
43. Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW.
Ciliary neurotrophic factor activates spinal cord astrocytes,
stimulating their production and release of FGF-2, to increase
motor neuron survival. Exp Neurol. 2002;173:46–62.
44. Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator
of neuroinflammation. J Neurosci Res. 2004;78:151–156.
45. Steinle JJ, Pierce JD, Clancy RL, G Smith P. Increased ocular
blood vessel numbers and sizes following chronic sympathec-
tomy in rat. Exp Eye Res. 2002;74:761–768.
46. Basu S, Sarkar C, Chakroborty D, Nagy J, Mitra RB, Dasgupta
PS, et al. Ablation of peripheral dopaminergic nerves
stimulates malignant tumor growth by inducing vascular
permeability factor/vascular endothelial growth factor-mediat-
ed angiogenesis. Cancer Res. 2004;64:5551–5555.
47. David Dong ZM, Aplin AC, Nicosia RF. Regulation of
angiogenesis by macrophages, dendritic cells, and circulating
myelomonocytic cells. Curr Pharm Des. 2009;15:365–379.
48. Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A,
van Rooijen N, et al. Contribution of macrophages to
angiogenesis induced by vascular endothelial growth factor
receptor-3-specific ligands. Am J Pathol. 2009;175:1984–1992.
49. Karakousis PC, John SK, Behling KC, Surace EM, Smith JE,
Hendrickson A, et al. Localization of pigment epithelium
derived factor (PEDF) in developing and adult human ocular
tissues. Mol Vis. 2001;7:154–163.
820 Ferrari et al. IOVS, January 2013, Vol. 54, No. 1
